Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Gene-based adjuvants: a new meaning.

Lu S.

Hum Gene Ther. 2009 Oct;20(10):1101-2. doi: 10.1089/hum.2009.910. No abstract available.

PMID:
19848597
[PubMed - indexed for MEDLINE]
2.

Adjuvant formulations and delivery systems for DNA vaccines.

Sasaki S, Takeshita F, Xin KQ, Ishii N, Okuda K.

Methods. 2003 Nov;31(3):243-54. Review.

PMID:
14511957
[PubMed - indexed for MEDLINE]
3.

Molecular adjuvants for mucosal immunity.

Toka FN, Pack CD, Rouse BT.

Immunol Rev. 2004 Jun;199:100-12. Review.

PMID:
15233729
[PubMed - indexed for MEDLINE]
4.

Genetic adjuvants for DNA vaccines.

Scheerlinck JY.

Vaccine. 2001 Mar 21;19(17-19):2647-56. Review.

PMID:
11257404
[PubMed - indexed for MEDLINE]
5.

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination.

Carson DA, Raz E.

J Exp Med. 1997 Nov 17;186(10):1621-2. Review. No abstract available.

PMID:
9411016
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

CpG oligonucleotides as immune adjuvants.

Krieg AM.

Ernst Schering Res Found Workshop. 2000;(30):105-18. Review. No abstract available.

PMID:
10943319
[PubMed - indexed for MEDLINE]
7.

Engineering of DNA vaccines using molecular adjuvant plasmids.

Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB.

Dev Biol (Basel). 2000;104:187-98. Review.

PMID:
11713819
[PubMed - indexed for MEDLINE]
8.

Immune responses to DNA vaccines.

Kowalczyk DW, Ertl HC.

Cell Mol Life Sci. 1999 May;55(5):751-70. Review.

PMID:
10379361
[PubMed - indexed for MEDLINE]
9.

Optimisation of DNA vaccines for the prophylaxis and modulation of herpes simplex virus infections.

Eo SK, Pack C, Kumaraguru U, Rouse BT.

Expert Opin Biol Ther. 2001 Mar;1(2):213-25. Review.

PMID:
11727531
[PubMed - indexed for MEDLINE]
10.

Cytokine gene-engineered vaccines.

Forni G, Boggio K.

Curr Opin Mol Ther. 1999 Feb;1(1):34-8. Review.

PMID:
11249681
[PubMed - indexed for MEDLINE]
11.

Mucosal immunization with DNA vaccines.

Hobson P, Barnfield C, Barnes A, Klavinskis LS.

Methods. 2003 Nov;31(3):217-24. Review.

PMID:
14511954
[PubMed - indexed for MEDLINE]
12.

Adjuvant activity of CpG oligodeoxynucleotides.

Klinman DM.

Int Rev Immunol. 2006 May-Aug;25(3-4):135-54. Review.

PMID:
16818369
[PubMed - indexed for MEDLINE]
13.

Chemical adjuvants for plasmid DNA vaccines.

Greenland JR, Letvin NL.

Vaccine. 2007 May 10;25(19):3731-41. Epub 2007 Feb 20. Review.

PMID:
17350735
[PubMed - indexed for MEDLINE]
14.

DNA vaccine strategies: candidates for immune modulation and immunization regimens.

Doria-Rose NA, Haigwood NL.

Methods. 2003 Nov;31(3):207-16. Review.

PMID:
14511953
[PubMed - indexed for MEDLINE]
15.

Recent developments in adjuvants for vaccines against infectious diseases.

O'Hagan DT, MacKichan ML, Singh M.

Biomol Eng. 2001 Oct 15;18(3):69-85. Review.

PMID:
11566599
[PubMed - indexed for MEDLINE]
16.

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants.

Calarota SA, Weiner DB.

Immunol Rev. 2004 Jun;199:84-99. Review.

PMID:
15233728
[PubMed - indexed for MEDLINE]
17.

DNA vaccines.

Spiegelberg HL, Raz E.

Allergy. 1999;54 Suppl 56:47-8. Review. No abstract available.

PMID:
10532307
[PubMed - indexed for MEDLINE]
18.

DNA vaccine.

Cui Z.

Adv Genet. 2005;54:257-89. Review.

PMID:
16096015
[PubMed - indexed for MEDLINE]
19.

The potential of topical DNA vaccines adjuvanted by cytokines.

Lisziewicz J, Calarota SA, Lori F.

Expert Opin Biol Ther. 2007 Oct;7(10):1563-74. Review.

PMID:
17916048
[PubMed - indexed for MEDLINE]
20.

DNA vaccination: an update.

Lowrie DB.

Methods Mol Med. 2003;87:377-90. Review. No abstract available.

PMID:
12958468
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk